Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 100% increase over the number of companies cited in the previous quarter.
The citations in the county include:
- The organizational structure has not been adequately established and maintained to ensure that devices are designed and produced in accordance with 21 CFR 820.
- Procedures for training and identifying training needs have not been adequately established.
- The design history file does not demonstrate that the design was developed following the requirements of 21 CFR 820.
Both companies cited were involved in either Devices or Biologics sectors.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Greater Baltimore Medical Center | Biologics | 10/26/2023 | Equipment observed, standardized, calibrated |
Greater Baltimore Medical Center | Biologics | 10/26/2023 | SOPs for investigations, records |
Shikani Medical, LLC | Devices | 12/21/2023 | Lack of or inadequate organizational structure |
Shikani Medical, LLC | Devices | 12/21/2023 | Training - Lack of or inadequate procedures |
Shikani Medical, LLC | Devices | 12/21/2023 | Design history file |
Shikani Medical, LLC | Devices | 12/21/2023 | Evaluation and Selection, Suppliers, Contractors, etc. |
Shikani Medical, LLC | Devices | 12/21/2023 | Lack of or inadequate receiving acceptance procedures |
Shikani Medical, LLC | Devices | 12/21/2023 | Lack of or inadequate complaint procedures |